Since 2009, there has been no improvement in meeting the American Academy of Pediatrics guidelines for vitamin D intake.
Factors during gestation and infancy may impact bone health in young adulthood.
Implementation of the 2010 Healthy, Hunger-Free Kids Act significantly cut childhood obesity among children living in poverty.
Migraine attacks were more frequent in post-pubertal compared to pre-pubertal girls, with no observed difference in headache characteristics between the groups.
Exclusive breastfeeding to 5 months can attenuate the impact of genetic risk on body mass index increase during childhood.
Metabolic traits associated with adult diabetes risk may be detectable by age 8 years.
Higher body weight was found to be associated with lower T2-weighted hippocampal signal intensity in adolescents aged 12 to 18 years.
A lifestyle intervention utilizing broad dietary recommendations may improve fatigue and sleep scores in children with subclinical hypothyroidism.
The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.
Obesity is the most common comorbidity among children and adolescents with COVID-19 and is associated with disease severity.